These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18763225)

  • 1. Choreatic symptoms during and after treatment with paliperidone and escitalopram.
    Hüther R; Gebhart C; Mirisch S; Bäuml J; Förstl H
    Pharmacopsychiatry; 2008 Sep; 41(5):203-4. PubMed ID: 18763225
    [No Abstract]   [Full Text] [Related]  

  • 2. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
    Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
    [No Abstract]   [Full Text] [Related]  

  • 3. Paliperidone-induced leukopenia and neutropenia: a case report.
    Kim JN; Lee BC; Choi IG; Jon DI; Jung MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):284-5. PubMed ID: 20920543
    [No Abstract]   [Full Text] [Related]  

  • 4. Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder.
    Liang CS; Yang FW; Huang YC
    J Clin Psychopharmacol; 2012 Oct; 32(5):720-1. PubMed ID: 22926613
    [No Abstract]   [Full Text] [Related]  

  • 5. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to paliperidone.
    Hsu WY; Chiu NY
    J Clin Psychopharmacol; 2013 Oct; 33(5):712-3. PubMed ID: 23899637
    [No Abstract]   [Full Text] [Related]  

  • 6. Paliperidone-induced mania-like symptoms: a case report.
    Wang WT; Chen CH; Lu ML; Lai TJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1351-2. PubMed ID: 20600461
    [No Abstract]   [Full Text] [Related]  

  • 7. Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression.
    Wand AP
    Aust N Z J Psychiatry; 2012 Feb; 46(2):178. PubMed ID: 22311539
    [No Abstract]   [Full Text] [Related]  

  • 8. Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E36-7. PubMed ID: 24763786
    [No Abstract]   [Full Text] [Related]  

  • 9. Citalopram-associated spontaneous ejaculations.
    Virit O; Savas HA
    J Clin Psychopharmacol; 2008 Jun; 28(3):360-1. PubMed ID: 18480704
    [No Abstract]   [Full Text] [Related]  

  • 10. Manic symptoms induced by paliperidone.
    Hsieh CH; Liou YJ
    J Clin Psychopharmacol; 2010 Apr; 30(2):202-4. PubMed ID: 20520298
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose escitalopram-associated hyponatremia.
    Pae CU; Park GY; Im S; Ko SB; Lee SJ
    Asia Pac Psychiatry; 2013 Jun; 5(2):E90. PubMed ID: 23857817
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
    Teng PR; Lane HY
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
    [No Abstract]   [Full Text] [Related]  

  • 13. Paliperidone-related rabbit syndrome.
    Teng PR; Lai TJ
    J Clin Psychopharmacol; 2011 Jun; 31(3):379-80. PubMed ID: 21532365
    [No Abstract]   [Full Text] [Related]  

  • 14. [Citalopram].
    Taéron C
    Rev Infirm; 2008 Nov; (145):47-9. PubMed ID: 19044198
    [No Abstract]   [Full Text] [Related]  

  • 15. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.
    Chokka P; Legault M
    Depress Anxiety; 2008; 25(12):E173-81. PubMed ID: 19006260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
    Han C; Lee SJ; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of Escitalopram-Induced Sweating With Citalopram.
    Kolli V; Rainville CT
    Prim Care Companion CNS Disord; 2017 Apr; 19(2):. PubMed ID: 28426928
    [No Abstract]   [Full Text] [Related]  

  • 19. Lactation associated with fluoxetine treatment.
    Arya DK; Taylor WS
    Aust N Z J Psychiatry; 1995 Dec; 29(4):697. PubMed ID: 8825840
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement in psychotic symptoms and social functioning after augmentation of paliperidone with clozapine in a patient with schizoaffective disorder.
    Hou YC
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E26. PubMed ID: 24515699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.